Doutor Agora

What Doutor Agora does

Doutor Agora is a private Brazilian B2B healthcare services company founded in 2016 and headquartered in Belo Horizonte, Minas Gerais. The company describes itself as the pioneer of the Shared Clinics (White Label) model in Brazil, targeting health insurance operators and self-management entities (operadoras de autogestão) — typically corporates, public institutions, professional associations, and labor unions that run their own health benefit programs (e.g., CASSI for Banco do Brasil, CEMIGSAÚDE for CEMIG). Its offering centralizes clinical infrastructure, standardizes care protocols, and provides technology-enabled care coordination including risk stratification, continuous telemonitoring, and active patient monitoring for the operator's beneficiary population.

The platform underpins three integrated product lines: APS (Clínicas de Atenção Primária Compartilhadas), shared primary care clinics that act as the care-coordination hub; CIC (Clínica de Infusão Compartilhada), shared specialty infusion centers for high-cost therapies in rheumatology, dermatology, gastroenterology, and neurology; and Acolher Neuro, a multidisciplinary neurodevelopment unit for children and adolescents (0-17 years) with conditions such as autism, ADHD, cerebral palsy, and genetic syndromes. Operating data shows 14 units across Minas Gerais (including Brumadinho, Uberlândia, Juiz de Fora, Governador Valadares, Divinópolis, Pouso Alegre, Diamantina, Contagem, Montes Claros, and Ipatinga), 48,076 beneficiaries served, 152,000+ appointments performed, 18,000+ telemonitoring sessions, and 96% of beneficiaries risk-stratified.

Doutor Agora generates revenue through managed-services and subscription-recurring contracts with health operators under a quote-based pricing model tailored to population size, risk profile, and service scope. Go-to-market is enterprise field sales via direct outreach, supported by website lead capture and WhatsApp Business. The company has been recognized with the national Prêmio UNIDAS award and the Certificação em Boas Práticas de Atenção Primária à Saúde, and currently maintains strategic partnerships with at least eight named self-management operators including CASSI, CEMIGSAÚDE, USISAÚDE, PASA, AMMP, CASU, COPASS, and FUNDAFEMG.

Name

Doutor Agora

Legal name

Doutor Agora

Website

https://doutoragora.com.br

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Doutor Agora is a private Brazilian B2B healthcare services company that pioneered the Shared Clinics (White Label) model for self-management health operators. It operates APS primary care, CIC infusion, and Acolher Neuro developmental lines across 14 units in Minas Gerais, serving 48,076 beneficiaries.

Ownership category

akta.pro rank

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices14 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Shared Clinic Services (White Label): Revenue generated from operating shared clinical infrastructure for health operators and self-management entities. The model includes shared structure costs, standardized clinical protocols, and operational efficiency gains shared between Doutor Agora and partner operators.
2. Healthcare Service Delivery: Direct delivery of healthcare services including primary care, infusion therapy, and neurodevelopment care through owned and operated clinic units.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Doutor Agora is a B2B healthcare services company that operates a shared clinic (White Label) model in Brazil, providing primary care, high-cost infusion therapy, and neurodevelopmental care to health operators and self-management entities (autogestões). Through 14 units in Minas Gerais, it delivers integrated multidisciplinary clinical services with risk stratification, telemonitoring, and care coordination across three product lines: APS (Primary Care), CIC (Infusion Therapy), and Acolher Neuro (Neurodevelopment).

Product overview

Doutor Agora is a B2B healthcare services company and pioneer in the Shared Clinics (White Label) model in Brazil. The company operates three integrated product lines: Clínicas de Atenção Primária Compartilhadas (APS) as the primary care coordination hub, Clínica de Infusão Compartilhada (CIC) for high-cost infusion therapies, and Clínica Acolher Neuro for neurodevelopmental care. All three operate under the shared clinic model, optimizing resources, standardizing processes, and enabling scalability for health operators and self-management entities.

Differentiator

Problem solved

Functional benefit

Brands

• Acolher Neuro: Specialized multidisciplinary unit for children and adolescents aged 0-17 with neurodevelopmental disorders, including Autism Spectrum Disorder (ASD), ADHD, intellectual disability, communication disorders, specific learning disorders, motor disorders, cerebral palsy, and genetic syndromes.
• CIC (Clínica de Infusão Compartilhada)
• APS (Clínicas de Atenção Primária Compartilhadas)

Products and services

• Clínicas de Atenção Primária Compartilhadas (APS) Primary care shared clinics serving as the entry point and care coordinator for the patient's journey, providing continuous follow-up, risk stratification, and active population health management for beneficiaries of health operators and self-management entities.
• Clínica de Infusão Compartilhada (CIC) Specialized solution for administration of high-cost infusion therapies, integrating clinical care, pre-infusion medical evaluation, logistics management, and continuous patient telemonitoring in Rheumatology, Dermatology, Gastroenterology, Neurology, and other specialties.
• Clínica Acolher Neuro Multiprofessional neurodevelopmental care solution for children and adolescents aged 0-17 with suspected or confirmed neurodevelopmental disorders, including Autism Spectrum Disorder (ASD), ADHD, intellectual disability, communication disorders, learning disorders, motor disorders, cerebral palsy, and genetic syndromes, with integrated care from Psychology, Occupational Therapy, Speech Therapy, Physiotherapy, Psychopedagogy, Neuropediatrics, Nutrition, and Musicotherapy.

Quantifiable outcome

• 48,076 beneficiaries served across 14 units
• +6 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• Operadoras de Autogestão (10 self-management health operators)coreStrategic or Co-development PartnerStrategic partnerships with 10 self-management health operators to provide shared clinic services including primary care, infusion therapy, and neurodevelopment care. These partnerships involve co-developing customized healthcare solutions that integrate with the operators' existing health benefit programs.
• USISAÚDEcoreStrategic or Co-development PartnerHealth operator partner using the Acolher Neuro solution for neurodevelopmental care of beneficiaries, with operations at the Ipatinga unit.
• CEMIGSAÚDEcoreStrategic or Co-development PartnerSelf-management health plan of CEMIG (Companhia Energética de Minas Gerais) operating multiple shared clinic services including infusion therapy and primary care.
• CASSIcoreStrategic or Co-development PartnerSelf-management health plan for Banco do Brasil employees, using Acolher Neuro services for neurodevelopmental care.
• AMMP (Associação dos Magistrados Mineiros)coreStrategic or Co-development PartnerAssociation of Minas Gerais magistrates using shared clinic services for their members.
• PASAcoreStrategic or Co-development PartnerSelf-management health plan partner using infusion clinic services for high-cost therapies.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Hapvida NotreDame Intermédica: Brazil's largest integrated health plan and provider with vertical integration across payer and care delivery. Comparable because it pursues cost control through owned care infrastructure, though at much larger scale and with a payer-led rather than B2B-services model.
• Amil: Major Brazilian health insurer owned by UnitedHealth Group, operating integrated care delivery assets. Comparable as a large buyer of healthcare services in Brazil pursuing cost control, though Amil delivers care through owned networks rather than a White Label model.
• Unimed: Brazil's largest cooperative health system with hundreds of local cooperatives providing care to members nationwide. Comparable as a major healthcare delivery network serving self-management and cooperative members, but organized as a cooperative federation rather than a single B2B services operator.
• Rede D'Or São Luiz: Brazil's largest private hospital network operating across multiple states. Comparable as a major private healthcare delivery platform in Brazil, though focused on hospital care rather than shared primary-care/infusion clinics for self-management operators.
• Hospital Israelita Albert Einstein: One of Brazil's premier hospital systems with an integrated health plan and B2B services. Comparable because it operates private healthcare delivery at scale with quality accreditation, though its scope is much broader than Doutor Agora's focused shared-clinic model.
• SulAmérica: One of Brazil's largest health insurance operators with growing provider-side investments. Comparable as a counterparty type (health operator seeking cost-control solutions), but operates as a payer rather than a shared-services provider.
• Hospital Moinhos de Vento: Major Brazilian hospital system in southern Brazil with quality accreditation and corporate health programs. Comparable as a high-quality private healthcare provider with enterprise health offerings, though focused on hospital services rather than shared primary-care clinics.
• Prevent Senior: Brazilian health plan focused on the elderly population with vertically integrated provider networks. Comparable because it serves chronic-care-heavy populations and pursues cost control through owned care, though at payer scale rather than as a B2B services company.

Emerging players

• Keralty: Latin American integrated health operator running health plans and provider networks across multiple countries. Comparable as a vertically integrated care model targeting cost control, though operating at much larger geographic scale and with payer ownership.

Others

• Dasa: Brazil's largest medical diagnostics company serving health operators and self-management plans. Comparable as a B2B health-services platform in Brazil with similar operator customers, but operates in diagnostics rather than primary care, infusion, and neurodevelopment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• Xx.com/doutor_agora
• Facebookfacebook.com/clinicadoutoragora
• LinkedInlinkedin.com/company/doutor-agora-pronto-atendimento

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doutor Agora